HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Press Releases
  • >Archive 2000-2020
  • >2014
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
      • Archive 2000-2020
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
        • 2012
        • 2011
        • 2000
        • 2001
        • 2002
        • 2003
        • 2004
        • 2005
        • 2006
        • 2007
        • 2008
        • 2009
        • 2010
    • COVID-19
    • BREXIT
    • Nitrosamine impurities
    • Procedural Guidance
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
    • Falsified Medicines
    • Questions & Answers
    • Contact Points
    • Recently Published history
  • MRI Product Index
  • Pharmacovigilance
  • Availability of Medicines
  • Publications and reports
  • National Contacts

 

CMDh Press Releases - 2014

  • Report form the meeting held on 15-17 December 2014
  • Report from the meeting held on 17-19 November 2014
  • Report from the meeting held on 20-22 October 2014
  • Report from the meeting held on 22-24 September 2014 
    (Information on Domperidone-containing medicines (Art.31 referral) updated on 3 October 2014)
  • Report from the meeting held on 21-23 July 2014
  • Report from the meeting held on 23-25 June 2014
  • Report from the meeting held on 19-21 May 2014
  • Report from the meeting held on 22-24 April 2014
  • Report from the meeting held on 17-19 March 2014 
    (Information on influenza vaccines updated on 1 April 2014)
  • Report from the meeting held on 17-19 February 2014
  • Report from the meeting held on 20-22 January 2014

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/human-medicines/cmdh/press-releases/archive-2000-2019/2014.html